Operating Lease, Right-of-Use Asset of Nautilus Biotechnology, Inc. from 31 Dec 2020 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Nautilus Biotechnology, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2020 to 31 Dec 2025.
  • Nautilus Biotechnology, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $27,773,000, a 1.7% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Nautilus Biotechnology, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $27,773,000 -$483,000 -1.7% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 $24,727,000 -$4,650,000 -16% 30 Sep 2025 10-Q 28 Oct 2025 2025 Q3
Q2 2025 $25,920,000 -$4,554,000 -15% 30 Jun 2025 10-Q 31 Jul 2025 2025 Q2
Q1 2025 $27,096,000 -$4,463,000 -14% 31 Mar 2025 10-Q 29 Apr 2025 2025 Q1
Q4 2024 $28,256,000 -$4,378,000 -13% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 $29,377,000 -$4,292,000 -13% 30 Sep 2024 10-Q 29 Oct 2024 2024 Q3
Q2 2024 $30,474,000 -$4,210,000 -12% 30 Jun 2024 10-Q 30 Jul 2024 2024 Q2
Q1 2024 $31,559,000 -$4,144,000 -12% 31 Mar 2024 10-Q 30 Apr 2024 2024 Q1
Q4 2023 $32,634,000 +$3,768,000 +13% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $33,669,000 +$5,916,000 +21% 30 Sep 2023 10-Q 31 Oct 2023 2023 Q3
Q2 2023 $34,684,000 +$6,380,000 +23% 30 Jun 2023 10-Q 02 Aug 2023 2023 Q2
Q1 2023 $35,703,000 +$6,851,000 +24% 31 Mar 2023 10-Q 02 May 2023 2023 Q1
Q4 2022 $28,866,000 -$511,000 -1.7% 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q3 2022 $27,753,000 +$24,068,000 +653% 30 Sep 2022 10-Q 01 Nov 2022 2022 Q3
Q2 2022 $28,304,000 +$27,476,000 +3318% 30 Jun 2022 10-Q 02 Aug 2022 2022 Q2
Q1 2022 $28,852,000 31 Mar 2022 10-Q 03 May 2022 2022 Q1
Q4 2021 $29,377,000 +$24,535,000 +507% 31 Dec 2021 10-K 23 Feb 2023 2022 FY
Q3 2021 $3,685,000 30 Sep 2021 10-Q 02 Nov 2021 2021 Q3
Q2 2021 $828,000 30 Jun 2021 10-Q 10 Aug 2021 2021 Q2
Q4 2020 $4,842,000 31 Dec 2020 10-K 24 Feb 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.